Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network · 2026-04 · 24 (4)
DOI: 10.6004/jnccn.2026.0017 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-04. Verfasst von Gregory J Riely und 40 weiteren Autor:innen. Beteiligte Einrichtung: 1Memorial Sloan Kettering Cancer Center. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Medical Oncology. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 362 Literaturangaben. Gefördert von: AstraZeneca, Johnson & Johnson, Lantheus, Lilly, Novartis, and Recordati Rare Diseases Inc, GSK, Exelixis, Inc.
Abstract (Originalsprache)
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance, and subsequent treatment. The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data. This selection from the NCCN Guidelines for NSCLC focuses on treatment recommendations for advanced or metastatic NSCLC with actionable biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- 1Memorial Sloan Kettering Cancer Center.
- 2Fred Hutchinson Cancer Center.
- 3University of Colorado Cancer Center.
- 4University of Wisconsin Carbone Cancer Center.
- 5Fox Chase Cancer Center.
- 6Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Förderung
- AstraZeneca, Johnson & Johnson, Lantheus, Lilly, Novartis, and Recordati Rare Diseases Inc
- GSK
- Exelixis, Inc
Zitieren
APA
Riely, G. J., Wood, D. E., Aisner, D. L., Axtell, A. L., Bauman, J. R., Bharat, A., Chang, J. Y., Desai, A., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Juloori, A., Lackner, R. P., Lanuti, M., Levy, B., Lin, J., …, & Hang, L. (2026). Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 24(4). https://doi.org/10.6004/jnccn.2026.0017
Vancouver
Riely GJ, Wood DE, Aisner DL, Axtell AL, Bauman JR, Bharat A, et al. Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network. 2026;24(4). doi:10.6004/jnccn.2026.0017
BibTeX
@article{Riely2026,
author = {Riely, Gregory J and Wood, Douglas E and Aisner, Dara L and Axtell, Andrea L and Bauman, Jessica R and Bharat, Ankit and Chang, Joe Y and Desai, Aakash and Dilling, Thomas J and Dowell, Jonathan and Durm, Gregory A and Gettinger, Scott and Grotz, Travis E and Gubens, Matthew A and Juloori, Aditya and Lackner, Rudy P and Lanuti, Michael and Levy, Benjamin and Lin, Jules and Loo, Billy W and Lovly, Christine M and Maldonado, Fabien and Morgensztern, Daniel and Mullikin, Trey C and Ng, Thomas and Owen, Dawn and Owen, Dwight H and Patil, Tejas and Polanco, Patricio M and Riess, Jonathan and Mendez, Ana Lucia Ruano and Shapiro, Theresa A and Singh, Aditi P and Stevenson, James and Tam, Alda and Tanvetyanon, Tawee and Yanagawa, Jane and Yau, Edwin and Yun, Karen and Gregory, Kristina and Hang, Lisa},
title = {Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {4},
doi = {10.6004/jnccn.2026.0017}
}
EUVIMED